310 related articles for article (PubMed ID: 15255546)
1. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
[TBL] [Abstract][Full Text] [Related]
3. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
5. [New promising anticancer drugs for lung cancer].
Ariyoshi Y; Sugiura T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
[TBL] [Abstract][Full Text] [Related]
6. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
Ferrigno D; Buccheri G
Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
[TBL] [Abstract][Full Text] [Related]
7. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
Hanada M; Noguchi T; Yamaoka T
Cancer Sci; 2007 Mar; 98(3):447-54. PubMed ID: 17214744
[TBL] [Abstract][Full Text] [Related]
8. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer.
Lissoni P; Messina G; Balestra A; Colciago M; Brivio F; Fumagalli L; Fumagalli G; Parolini D
In Vivo; 2008; 22(2):257-62. PubMed ID: 18468412
[TBL] [Abstract][Full Text] [Related]
10. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Bunn PA; Kelly K
Clin Cancer Res; 1998 May; 4(5):1087-100. PubMed ID: 9607565
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS
Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595
[TBL] [Abstract][Full Text] [Related]
12. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
13. New chemotherapeutic agents for non-small cell lung cancer.
Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
15. [New wave of chemotherapeutic agents: update in pulmonary oncology].
Sculier JP
Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
[No Abstract] [Full Text] [Related]
16. New agents in the treatment of small cell lung cancer.
Ghaemmaghami M; Jett JR
Chest; 1998 Jan; 113(1 Suppl):86S-91S. PubMed ID: 9438696
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
Sanal SM; Gokmen E; Karabulut B; Sezgin C
Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
[TBL] [Abstract][Full Text] [Related]
18. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
19. The role of new agents in advanced non-small-cell lung carcinoma.
Langer CJ
Curr Oncol Rep; 2000 Jan; 2(1):76-89. PubMed ID: 11122828
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
Grivicich I; Mans DR; Peters GJ; Schwartsmann G
Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
